Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
00:00:12 Narrator On this episode, associate editor and clinical pharmacist, Vicki Danaher, shares practical guidance on how Orforglopron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, cost, and more in an excerpt from our popular Pharmacy Essential Updates webinar series
Cognitive impairment or dementia in post-acute COVID-19 syndrome
Initiation of opioid prescription and risk of suicidal behavior among youth and young adults
Though the AAOph and the North American Neuro-Ophthalmology Society do not recommend that people stop taking semaglutide at this time, they reiterate that further research will help clarify the relationship between the drug and ocular events such as NAION.
Pharmacol Res
US$ 21.67
US$ 24.25
US$ 23.41
US$ 28.56
US$ 25.08
